David Seftel, MD, MBA (Harvard)

Physician, scientist, entrepreneur, agent of innovation and global progress

[David Seftel, MD, MBA (Harvard) @DSeftel]

@DiedSuddenly_ Conclusion
This finding actually underscores the importance of staying up-to-date on boosters. People ages 12 and older who have had a bivalent booster shot have a 15 times lower risk of death than an unvaccinated person.

[David Seftel, MD, MBA (Harvard) @DSeftel]

I have three more documented cases like this.

[David Seftel, MD, MBA (Harvard) @DSeftel]

Our work at Enable Biosciences in developing one of world's best neutralizing antibody tests for COVID is front page news in many Bay Area Newspapers - https://t.co/n4NYFnG9dF

[David Seftel, MD, MBA (Harvard) @DSeftel]

@elandhuis Esther, you were a pioneer in peerless reporting on the this promising prospect! Thank you for your exceptional writing in this regard. Kudos!

[David Seftel, MD, MBA (Harvard) @DSeftel]

@elandhuis You were a pioneer in peerless reporting on the this promising prospect! Thank you for your exceptional writing in this regard. Kudos!

[David Seftel, MD, MBA (Harvard) @DSeftel]

An absolutely excellent paper, a powerful and persuasive metanalysis and review. Kudos!

[David Seftel, MD, MBA (Harvard) @DSeftel]

@stkirsch I am honored to have you as my first follower Steve!

[David Seftel, MD, MBA (Harvard) @DSeftel]

My Harvard Business Association of Northern California COVID-19 webinar contributes to a convergence of science and medicine to produce promising news on a therapeutic option for COVID - watch CBS 60 Minutes March 7, 2021 segment: "The Long Shot" - https://t.co/emqaHql2Q4

[David Seftel, MD, MBA (Harvard) @DSeftel]

@AbdenurFlavio @stkirsch We are all in it together!

[David Seftel, MD, MBA (Harvard) @DSeftel]

Thanks for all the wonderful feedback on the 60 minutes segment - now Steve Kirsch and I at the COVID Early Treatment Fund (CETF) https://t.co/BBUqXK28r7 your help to accelerate the further evaluation and parallel use in practice of well qualified repurposed drugs.

[David Seftel, MD, MBA (Harvard) @DSeftel]

Prospective Cohort of Fluvoxamine for Early Treatment of Coronavirus Disease 19 https://t.co/xEn3q5aBCR